India’s race for the CDMO crown
For years, China+1 has been the big story in India's CDMO opportunity. Now, it is no longer enough. The shift away from China is…
Author
Zydus gets final US FDA approval for Ascorbic Acid Injection with 180-Days CGT exclusivity
The product is primarily used for the short-term treatment of scurvy in adult and paediatric patients aged 5 months and older for…
India-US pharma ties look beyond generics
Sergio Gor, US Ambassador to India and Devendra Fadnavis, Maharashatra CM pitch deeper R&D, investment and co-development, at…
Inside Shilpa Medicare’s growth strategy: Quality, digital and global ambitions
Dr Vellaian Karuppiah, COO-Management, Shilpa Medicare shares his vision for building a future-ready organisation powered by…
Power, politics and pharma
In a world shaped by geopolitics, economic nationalism and heightened scrutiny on quality and resilience, India's next phase of…
FDD Leadership Awards spotlight FR&D excellence
Continuing its tradition of recognising excellence, the FDD Leadership Awards 2026, held alongside the FDD Conclave 2026,…
FDD Conclave 2026: Charting the future of formulation science and drug delivery
The pharma industry is entering an era where scientific innovation must move faster, scale smarter and remain affordable. Against…
The new playbook for pharma manufacturing
Freight disruption,energy volatility,raw material dependencies and geopolitical tensions are reshaping pharma manufacturing. As a…
Gujarat’s bet on Jambusar
Between the Gulf of Khambhat and the Narmada, India is staking 3,920 crores on the Jambusar Bulk Drug Park in Bharuch, Gujarat.…
Leading people in the age of AI
As AI reshapes pharma, HR leadership is being drawn into a deeper question that goes beyond technology to the future of people and…